SCHEMBL3466498

SCHEMBL3466498

C=Cc1cccnc1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
ALDH1A1 P00352 4/20 0.36
LMNA P02545 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRA4 P48169 1/20 0.36
GABRA6 Q16445 1/20 0.36
NFE2L2 Q16236 1/20 0.36
KDM4E B2RXH2 3/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL535731 0.83 L3MBTL1 (0.55) L3MBTL1ALDH1A1NFE2L2KDM4EPOLB
SCHEMBL16239167 0.80 L3MBTL1 (0.37) METAP1L3MBTL1ALDH1A1LMNANFE2L2
SCHEMBL2148128 0.80 L3MBTL1 (0.37) L3MBTL1ALDH1A1NFE2L2KDM4EMAPT
SCHEMBL13379447 0.80 MAPK1 (0.39) L3MBTL1ALDH1A1NFE2L2KDM4EMAPT
SCHEMBL21358044 0.78 KDM4E (0.39) METAP1L3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL5376069 0.78 TLR7 (0.45) METAP1L3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL30441012 0.78 KDM4E (0.46) METAP1L3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL28085307 0.78 L3MBTL1 (0.41) METAP1L3MBTL1ALDH1A1LMNAKDM4E
SCHEMBL31628026 0.77 ALDH1A1 (0.41) L3MBTL1ALDH1A1NFE2L2KDM4EMAPT
SCHEMBL23971148 0.76 ALDH1A1 (0.37) ALDH1A1LMNAGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
EP-2265600-A1 PYRIDINYL AMIDES FOR THE TREATMENT OF CNS AND METABOLIC DISORDERS Pfizer Inc. (US) 2010-12-29 EP disclosed
WO-2009098576-A1 PYRIDINYL AMIDES FOR THE TREATMENT OF CNS AND METABOLIC DISORDERS PFIZER INC. (US) 2009-08-13 WO disclosed